Table 7.
Classification of the anti-HLA-E mAbs generated at TFL using heavy chain of HLA-E | |||||||
---|---|---|---|---|---|---|---|
Anti-HLA mAbs | Classical HLA (HLA-Ia) | Nonclassical HLA (HLA-Ib) | Characteristics of the groups of mAbs | ||||
Alleles -> | A | B | Cw | E | F | G | |
Group 1 | 0 | 0 | 0 | + | 0 | 0 | HLA-E monospecific |
Group 2 | 0 | 0 | 0 | + | + | 0 | HLA-F cross-reactive |
Group 3 | 0 | 0 | 0 | + | 0 | + | HLA-G cross-reactive |
Group 4 | 0 | 0 | 0 | + | + | + | HLA-Ib specific |
Group 5 | + | + | + | + | 0 | 0 | HLA-Ia polyreactive |
Group 6 | + | + | + | + | + | 0 | HLA-Ia/F polyreactive |
Group 7 | + | + | + | + | 0 | + | HLA-Ia/G polyreactive |
Group 8 | + | + | + | + | + | + | HLA class-I specific |
The monospecific monoclonal HLA-E antibodies recognize none of the other HLA-Ia or Ib molecules. TFL refers to Terasaki Foundation Laboratory in Los Angeles, where the antibodies were generated and characterized. The mAbs were monitored in Luminex SABs assay using regular LABSCreen beadsets.